Cramer Pamela J. bought RYTM

November 7, 2025 · Form 4 insider transaction

Cramer Pamela J. bought 10,546 shares of Rhythm Pharmaceuticals, Inc. at $6.80 per share, a transaction worth $71.7K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 5 days after the transaction.